The Rottenstein Law Group, which represents DePuy ASR recall clients, is closely monitoring the proceedings of the Los Angeles DePuy ASR hip trial (In re: Loren Kransky and Sheryl Kransky v. DePuy, Inc., et al., BC456086, Los Angeles Superior Court). Most recently, the jury heard testimony from a DePuy executive who denied that the recall occurred because the device was faulty. Andrew Ekdahl, president of Johnson & Johnson’s DePuy, said in videotaped testimony that the 93,000 DePuy ASR hip implants were recalled worldwide because they did not meet the clinical needs of the market and not because they were unsafe," according to a Bloomberg story.
“Thousands of people believe they were harmed by the DePuy ASR,” said Rochelle Rottenstein, principal of the Rottenstein Law Group. “It is important that these allegations are thoroughly explored in court.”
Loren Kransky, 65, of North Dakota, alleges that the DePuy ASR caused him metal poisoning, among other problems, according to court records. DePuy asserts that Kransky’s health problems are unrelated to his now-removed hip implant, according to Bloomberg. There are more than 10,000 DePuy ASR lawsuits pending across the United States, about 7,000 of which are consolidated for pretrial proceedings in multidistrict litigation in the United States District Court for the Northern District of Ohio (MDL-2197). About 33,000 people in the United States received the ASR implant, out of 93,000 worldwide, according to Bloomberg. The DePuy ASR recall occurred in 2010. Previous testimony** from witnesses suggested that DePuy knew of the ASR’s faults several years before the recall.
Read more: DePuy ASR Lawsuit Update: J&J executive testifies DePuy ASR recalled because of clinical needs, not failure, the Rottenstein Law Group reports
Complaints on hip implants continue piling up at the U.S. Food and Drug Administration (FDA) with 5,000 of them added this year alone. Some 75 percent of those claims involved the hip replacement systems of DePuy Orthopaedics Inc., a subsidiary of Johnson & Johnson. Several of those lawsuits have been consolidated into a multidistrict litigation (MDL), making it easier for initiating a hip replacement case. Due to the growing evidence against them, the British Hip Society has called for an in...
Reaching out to fellow Republicans and seeking bipartisan support, US Democrats aim to block of medical devices with safety issues, Bloomberg reports. They mentioned injuries from flawed medical products, including those manufactured and distributed by Johnson & Johnson.
In a statement released by the Democrats led by Representative Edward Markey of Massachusetts, he explained that the bill introduced would close a loophole that lets devices win approval on the basis of their similarityt to a...
The high failure rate of the ASR hip system was made public through the reports of the Australian National Joint Replacement Registry. The negative feedback thrown at the all-metal hip implant of DePuy Orthopaedics urged the company to recall the devices in 2009.Recent reports say that an Australian government agency might require doctors to report defective implants.
Evidences that point to the recall is being gathered and investigated by Australia, as was done by the United States. The dir... Continue reading...
Each year in the United States, about 200,000 to 300,000 hip replacement procedures are done, as tallied by the American Academy of Orthopedic Surgeons (AAOS). A greater number of these patients are older adults, 60 years old and up. In hip replacement, the damaged joint is removed and replaced with a new prosthetic device. Manufacturers of hip implants have marketed various designs of the device. DePuy Orthopedics recently initiated a campaign telling recipients’ stories to potential reci... Continue reading...
The ASR XL Acetabular System and ASR Hip Resurfacing System are orthopedic hip replacement devices manufactured by DePuy and both were recalled from the worldwide market in August of 2010. It was discovered by a foreign joint registry that these implants inherently have flaws that contributed to its high failure rate. Components from the hip replacements rub together that cause metal ions such as cobalt and chromium to get scraped off and be absorbed by the body into the bloodstream. Some DeP... Continue reading...
There is definitely no doubt about it. DePuy Orthopaedics should issued a recall the moment they knew that their implants were defective. In fact, they should have never released their ASR implants to the market, because they never underwent clinical testing procedures set forth by the Food and Drug Administration in the United States. It was eventually found out that the ASR XL Acetabular System and the ASR Hip Resurfacing System both had a failure rate of 12-13%. It can also affect 1 in eve... Continue reading...
DePuy Orthopaedics has manufactured their own patented brands of metal-on-metal hip implants, the ASR XL Acetabular System and the ASR Hip Resurfacing System, both of which have been deemed as defective and harmful for human use—at least most of them. Just this year, the controversial company announced a product recall on these hip implants as a response to the angry complaints of the recipients. Above all, DePuy is also willing to provide reimbursements to those who were affected.
Months have passed since the product recall was issued by DePuy Orthopaedics, a subsidiary of company giant Johnson & Johnson. Within this time frame, thousands have aired out their concerns regarding the defects of their hip implants, the ASR XL Acetabular System and the ASR Hip Resurfacing System, which both had a 13% failure rate. Typically, patients implanted with the faulty devices will experience pain, weakness and swelling in the hip region a few months or years after the hip replaceme...
Surgeries, being invasive procedures, have accompanying risks that are most likely to occur during the post-operative phase, when the patient is most vulnerable. Orthopedic surgeries are no exception, even if no internal organs are harmed. Hip replacements are commonly performed procedures, and the functionality of hip prosthetic devices implanted into the joints determines how a patient will react in the coming days.
The ideal duration for hip replacement patients to undertake rehabilitation ...
The Food and Drug Administration, a government department, is a branch responsible for ensuring the general public that all food, cosmetic and health care products for sale in the market are safe, hygienic and effective. That said, products from different manufacturers also hold the same responsibility in creating their products according to the set standards of safety, sanitation and effectiveness that the FDA strictly requires. Moreover, the FDA has regulatory processes to ensure that these...
